ASPI

ASP Isotopes Inc. Common Stock

Fundamental data last updated:September 7, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Chemicals

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

 


Analyze ASPI on TradingView

VALUATION

P/E

-5.33

Market Cap ($M USD)

$635.70M

Forward P/E

14.43

PEG

0.11

PRICE TO SALES

23.61

PRICE TO BOOK

3.20

EV / EBITDA

-4.05

5-Year Average P/E

Free Cash Flow Yield

-10.35%

DCF Value

$-3.53

Graham Number

N/A

Price to FCF

-9.66

EV to FCF

-10.49

Earnings Yield

-18.75%

FCF Yield

-10.35%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

-$1.43

Next Year EPS Growth Estimate

$0.53

Next Year Revenue Growth Estimate

$721.12M

Return on Equity (ROE)

-117.16%

FREE CASH FLOW

Operating Margin

-275.28%

Debt-to-Equity

1.06

Piotroski F-Score

3

Altman Z-Score

0.12

Return on Invested Capital (ROIC)

-14.33%

Current Ratio

4.39

Quick Ratio

4.37

Net Debt to EBITDA

-0.32

Interest Coverage

59.72

Gross Profit margin

17.62%

FCF PER SHARE

$-0.54

REVENUE PER SHARE

$0.22

Analyze ASPI on TradingView

Gainseekers Quantitative Analysis

Summary

ASPI Isotopes Inc. presents a perplexing valuation scenario. Despite a Forward P/E of 10.15 suggesting future profitability, the current Price/Earnings ratio of -2.88 and a negative DCF Value indicate severe mispricing concerns. The Altman Z-score of 0.32 raises red flags about financial distress, while the Earnings Yield of -34.76% underscores a lack of immediate earnings power. The market seems to be pricing in a turnaround, but the financial health remains precarious.

AI Exposure / Tech Reliance

Operating in the Chemicals industry, ASPI Isotopes Inc. is positioned to leverage AI for process optimization and cost reduction. However, the traditional nature of its sector may slow rapid tech adoption. Its resilience will depend on integrating AI into its supply chain and production processes.

The Bull Case

For the bullish investor, ASPI's Forward PEG ratio of 0.08 is a beacon of potential undervaluation, suggesting growth at a reasonable price. Despite a Piotroski F-Score of 3 indicating moderate financial health, the company's impressive Current Ratio of 12.18 showcases robust liquidity. The anticipated sales growth of over 72 billion percent next year hints at transformative revenue potential, making it an intriguing prospect for those betting on a turnaround.

The Bear Case

The bear case is stark, with ASPI's Return on Equity at a disastrous -202.44%, signaling severe inefficiencies. The Operating Margin of -239.80% and a Price/Sales ratio of 18.75 highlight a company struggling to convert sales into profit. Additionally, the stock's distance from its 52-week high by 169.33% suggests technical overextension, making it a risky bet without clear signs of operational improvement.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$13.00

Institutional Ownership %

1-Year Beta

3.27

Insider Buying % (6 Mo)

Distance to 52-Week High

89.41%

Distance to 52-Week Low

48.76%

EARNINGS SURPRISE %

21.43%

50-DAY SMA

$5.18

200-DAY SMA

$7.09

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.